Genetic engineering and enrichment of human nk cells for car-enhanced immunotherapy of hematological malignancies

HIGHLIGHTS

• who: Maren Soldierer from the Miltenyi Biotec, United States University Children's Hospital have published the research work: Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies, in the Journal: (JOURNAL)
• what: The authors intended to establish the transduction of primary human NK cells derived from peripheral blood in a feeder-cell-free and CliniMACS Prodigy™-compatible system using the NK MACS medium from Miltenyi Biotec and also addressed several issues in genetic engineering of NK cells, including optimized transgene_expression, alternative lentiviral pseudotypes, and transduction enhancers.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.